// App-Quantinova.ai

523 : Changing pattern for HER2 positivity due to updated ASCO/CAP guidelines for HER2 testing and its impact.

Researchers

Presenter

  • Mithun Vinod Shah

Principal Investigators

  • Anne E. Wiktor

  • Rhett P. Ketterling

  • Edith A. Perez

  • Robert B. Jenkins

  • Reid G. Meyer

  • Kathleen S. Tenner

  • Karla V. Ballman

Medical Centers

  • Mayo Clinic, Jacksonville, FL

  • Mayo Clinic, Rochester, MN

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Breast cancer

  • Solid malignancies

Biomarkers

  • erb-b2 receptor tyrosine kinase 2

  • Human epidermal growth factor receptor 2

Drug/Treatment

  • Trastuzumab

Outcome

  • Positive

Study Design

  • randomized

Phase

  • NA

Study Id's

  • NCT00005970

Sponsors

  • N/A

Result

  • Final

Copyright © 2026. QuantiNova All rights reserved